Showing results (2491-2500 of 5,227) with videos related to
Sort By:
Pageof 523
Antiviral Research|February 3, 2024
Miltefosine reduces coxsackievirus B3 lethality of mice with enhanced STAT3 activationChun Yu Zhang, Cheng-Huei Hung, Yi-Ling Hsiao, et al.Antiviral Research|January 21, 2024
High-throughput drug screen identifies calcium and calmodulin inhibitors that reduce JCPyV infectionAvery C S Bond, Mason A Crocker, Michael P Wilczek, et al.Antiviral Research|January 29, 2024
Human neural progenitor cell models to study the antiviral effects and neuroprotective potential of approved and investigational human cytomegalovirus inhibitorsMarta Trevisan, Anna Pianezzola, Marco Onorati, et al.Antiviral Research|January 8, 2024
Oral USC-093, a novel homoserinamide analogue of the tyrosinamide (S)-HPMPA prodrug USC-087 has decreased nephrotoxicity while maintaining antiviral efficacy against human adenovirus infection of Syrian hamstersAnn E Tollefson, Samantha B Riemann, Baoling Ying, et al.Antiviral Research|January 14, 2024
Promises and challenges of single-domain antibodies to control influenzaArne Matthys, Xavier SaelensAntiviral Research|April 5, 2024
Ebola-specific therapeutic antibodies from lab to clinic: The example of ZMappGary Wong, Kathrina Mae Bienes, Ara Xiii, et al.Antiviral Research|March 31, 2024
Glucocorticoid receptor and specificity protein 1 (Sp1) or Sp3, but not the antibiotic Mithramycin A, stimulates human alphaherpesvirus 1 (HSV-1) replicationFouad S El-Mayet, Vanessa Claire Santos, Nishani Wijesekera, et al.Antiviral Research|March 29, 2024
DDX20 positively regulates the interferon pathway to inhibit viral infectionZhiqiang Chen, Jinyu Zhang, Tingting Feng, et al.Antiviral Research|March 30, 2024
Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitorsKaustav Khatua, Yugendar R Alugubelli, Kai S Yang, et al.Antiviral Research|September 30, 2024
Comprehensive Herpesviruses Antiviral drug Resistance Mutation Database (CHARMD)Valentin Tilloy, Daniel Díaz-González, Lisa Laplace, et al.Pageof 523